ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 166 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,000,000 | +34.2% | 277,800 | 0.0% | 0.12% | +52.4% |
Q2 2019 | $745,000 | -9.4% | 277,800 | 0.0% | 0.08% | -14.6% |
Q1 2019 | $822,000 | +28.4% | 277,800 | -31.0% | 0.10% | +31.5% |
Q4 2018 | $640,000 | -71.9% | 402,800 | -34.8% | 0.07% | -68.0% |
Q3 2018 | $2,274,000 | +30.1% | 617,800 | 0.0% | 0.23% | +27.4% |
Q2 2018 | $1,748,000 | -29.5% | 617,800 | -7.5% | 0.18% | -41.3% |
Q1 2018 | $2,478,000 | +28.9% | 667,800 | 0.0% | 0.30% | +17.3% |
Q4 2017 | $1,923,000 | -49.6% | 667,800 | -21.4% | 0.26% | -46.6% |
Q3 2017 | $3,817,000 | +400.9% | 850,000 | +412.0% | 0.49% | +346.8% |
Q2 2017 | $762,000 | +9.0% | 166,000 | 0.0% | 0.11% | -1.8% |
Q1 2017 | $699,000 | +1.9% | 166,000 | 0.0% | 0.11% | -15.9% |
Q4 2016 | $686,000 | -100.0% | 166,000 | -37.6% | 0.13% | -61.4% |
Q3 2016 | $2,154,600,000 | +103736.1% | 266,000 | 0.0% | 0.34% | -7.1% |
Q2 2016 | $2,075,000 | +1.0% | 266,000 | 0.0% | 0.37% | -9.8% |
Q1 2016 | $2,054,000 | -28.4% | 266,000 | 0.0% | 0.41% | -6.0% |
Q4 2015 | $2,870,000 | +48.3% | 266,000 | -5.0% | 0.43% | +40.9% |
Q3 2015 | $1,935,000 | -22.0% | 280,000 | 0.0% | 0.31% | +3.4% |
Q2 2015 | $2,481,000 | -10.1% | 280,000 | 0.0% | 0.30% | -36.1% |
Q1 2015 | $2,761,000 | -38.8% | 280,000 | -23.9% | 0.47% | -64.3% |
Q4 2014 | $4,508,000 | +125.9% | 368,000 | +84.0% | 1.31% | +123.8% |
Q3 2014 | $1,996,000 | -20.1% | 200,000 | -39.4% | 0.58% | -21.2% |
Q2 2014 | $2,498,000 | – | 330,000 | – | 0.74% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
Bellevue Group AG | 240,000 | $991,000 | 0.20% |